Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2005-04-07
2011-12-13
Rooney, Nora (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S275100, C530S350000
Reexamination Certificate
active
08075898
ABSTRACT:
A safe and efficient recombinant mite allergen is provided as a therapeutic agent or a diagnostic agent for mite allergic diseases, which contains no anaphylaxis-inducing impurities. The following recombinant protein (a) or (b) is provided:(a) a protein comprising the amino acid sequence represented by SEQ ID NO: 2 or 35; or(b) a protein comprising an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 or 35 by deletion, substitution, or addition of one or several amino acids and having mite allergen activity.
REFERENCES:
patent: 5314991 (1994-05-01), Oka et al.
patent: 5876722 (1999-03-01), Yuuki et al.
patent: 5958415 (1999-09-01), Yuuki et al.
patent: 6060057 (2000-05-01), Thomas et al.
patent: 6086897 (2000-07-01), Thomas et al.
patent: 7101664 (2006-09-01), Katinger et al.
patent: 0473111 (1992-03-01), None
Ngo et al. ‘Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox’. The Protein Folding Problem and Tertiary Structure Prediction. Ed. K. Merz and S. Le Grand. Boston: Birkhauser, 1994. 491-495.
Blumenthal et al. ‘Definition of an Allergen.’ Allergens and Allergen Immunotherapy. Ed. R Lockey, S. Bukantz and J. Bousquet. New York: Marcel Decker, 2004. 37-50.
Skolnick et al. ‘From genes to protein structuree and function: novel applications of computational approaches in the genomic era.’ Trends in Biotech. 18:34-39, 2000.
Attwood et al. ‘The Babel of Bioinformatics.’ Science. 290(5491):471-473, 2000.
Thomas et al., “Characterization and Immunobiology of House Dust Mite Allergens,” International Archives of Allergy and Immunology, vol. 129, No. 1, pp. 1-18, (2002), XP009032860.
Masuda et al., “Positive Reactions to Common Allergens in 42 Atopic Dogs in Japan,” Veterinary Immunology and Immunopathology, Amsterdam, NL, vol. 73, No. 2, pp. 193-204, (2000), XP001157518.
Lee et al., “Protein Sequence Analysis of a Novel 103-kDaDermatophagoides pteronyssinusMite Allergen and Prevalence of Serum Immunoglobulin E Reactivity to rDer p 11 in Allergic Adult Patients,” Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology, vol. 34, No. 3, Mar. 2004, pp. 354-362, (2004), XP002463135.
Foster et al., “Comparison of Intradermal and Serum Testing for Allergen-specific IgE Using a Feepsilon RIalpha-based Assay in Atopic Dogs in the UK,” Veterinary Immunology and Immunopathology, vol. 93, No. 1-2, pp. 51-60, May 30, 2003, XP002463136.
Schumann et al., “Characterization of House Dust Mite and Scabies Mite Allergens by Use of Canine Serum Antibodies”, Am. J. Vet. Res., vol. 62, No. 9, pp. 1344-1348 (2001).
T. Tsukui et al., “Establishment of A Dog IgE Detection System Using a Recombinant Dog High-Affinity IgE Receptor α (FcεRIα) Chain”, The 136thMeeting of the Japanese Society of Veterinary Science, HS-9, p. 202 (2003), accompanied by an English language translation thereof.
K. Kurata et al., “Immunological Findings in 3 Dogs Clinically Diagnosed with Allergic Rhinitis”, J. Vet. Med. Sci., vol. 66, No. 1, pp. 25-29 (2004).
C. McCall et al., “Characterization and Cloning of a Major High Molecular Weight House Dust Mite Allergen (Der F 15) for Dogs”, Vet. Immunol. Immunopathol., vol. 78, pp. 231-247 (2001).
E. Weber et al., “Identification, Characterization, and Cloning of a Complementary DNA Encoding A 60-KD House Dust Mite Allergen (Der F 15) for Human Beings and Dogs”, K. Allergy Clin. Immunol., vol. 112, No. 1, pp. 79-86 (2003).
Iwabuchi Shigehiro
Tsujimoto Hajime
Tsukui Toshihiro
Greenblum & Bernstein P.L.C.
Nippon Zenyaku Kogyo Co., Ltd.
Rooney Nora
LandOfFree
Mite allergen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mite allergen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mite allergen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4270659